• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    OptimizeRx Corporation - Common Stock (NQ:OPRX)

    7.865 +0.155 (+2.01%)
    Streaming Delayed Price Updated: 2:05 PM EDT, Aug 24, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about OptimizeRx Corporation - Common Stock

    < Previous 1 2 3 4 5 6 7 8 9 Next >
    News headline image
    OptimizeRx (OPRX) Q2 2026 Earnings Call Transcript ↗
    AI software revenue grew 25% despite overall quarterly decline from customer inactivity. 
    Via The Motley Fool
    Topics Artificial Intelligence Earnings
    News headline image
    OptimizeRx Q2 Earnings Call Highlights ↗
    OptimizeRx (NASDAQ:OPRX) reported second-quarter fiscal 2026 revenue of $20.5 million, down 30% from $29.2 million a year earlier, while adjusted EBITDA totaled $4.9 million, management said on its... 
    Via MarketBeat
    Topics Earnings
    News headline image
    OptimizeRx Announces Finance Leadership Appointments to Support the Next Phase of Growth
    From OptimizeRx Corporation
    Via GlobeNewswire
    OptimizeRx Corp (NASDAQ:OPRX) Beats Q1 Estimates But Slashes 2026 Revenue Guidance ↗
    Via Chartmill
    OptimizeRx Corp (NASDAQ:OPRX) Beats Q4 Earnings Estimates but Offers Cautious 2026 Outlook ↗
    Via Chartmill
    News headline image
    OptimizeRx Reports Second Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    OptimizeRx Sets Second Quarter 2026 Conference Call for August 12, 2026, at 4:30 p.m. ET
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    OptimizeRx Appoints Veteran Point of Care Marketing Leader Sarah Bast as Chief Marketing Officer
    Leading pharmaceutical marketing executive joins leadership team to accelerate innovation and strengthen partnerships across the life sciences industry 
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    OptimizeRx Launches CopayCue™, a Next-Generation Copay Activation Solution Powered by Real-Time Prescribing Intent
    Enhanced technology delivers brand savings offers directly within the prescribing workflow, when HCP intent is highest 
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    OptimizeRx Launches Natural Language Audience Builder for Life Sciences DSPs and Agency Media Planning Platforms
    Patent-pending, embeddable NLAB technology enables pharma and agency marketers to build custom, verified HCP audiences using natural-language prompts 
    From OptimizeRx Corporation
    Via GlobeNewswire
    MissionIRNewsBreaks – OptimizeRx Corp. (NASDAQ: OPRX) Secures $35 Million Senior Credit Facility
    Via Investor Brand Network
    Topics Artificial Intelligence
    News headline image
    OptimizeRx to Participate in Upcoming Investor Conferences
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    DeepIntent Becomes First Healthcare DSP to Integrate OptimizeRx’s Authenticated EHR Network
    Powered by OptimizeRx’s new programmatic infrastructure, collaboration expands access to premium point of care inventory for life sciences marketers 
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    OptimizeRx (OPRX) Q1 2026 Earnings Transcript ↗
    OptimizeRx (OPRX) Q1 2026 Earnings Transcript 
    Via The Motley Fool
    News headline image
    OptimizeRx Q1 Earnings Call Highlights ↗
    OptimizeRx (NASDAQ:OPRX) reported first-quarter fiscal 2026 results that topped consensus expectations, while management lowered its full-year revenue outlook, citing continued caution among life... 
    Via MarketBeat
    Topics Earnings
    News headline image
    OptimizeRx Reports First Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    OptimizeRx Launches Programmatic Access to Authenticated EHR Advertising at Scale
    Expands life sciences marketers’ reach at the validated point of care, enabling DSPs to directly integrate with OptimizeRx’s trusted EHR network for the first time 
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    OptimizeRx Releases 2026 Environmental, Social, and Governance (ESG) Report
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    OptimizeRx Sets First Quarter 2026 Conference Call for May 12, 2026, at 4:30 p.m. ET
    From OptimizeRx Corporation
    Via GlobeNewswire
    Discover the top movers in Wednesday's pre-market session. ↗
    Via Chartmill
    News headline image
    OptimizeRx (OPRX) Q4 2025 Earnings Call Transcript ↗
    OptimizeRx (OPRX) Q4 2025 Earnings Call Transcript 
    Via The Motley Fool
    Topics Earnings
    News headline image
    UPDATE – OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    Whetstone Capital Exits GitLab as Enterprises Rethink AI-Driven Software Development Tools ↗
    Whetstone Capital Advisors has sold its stake in GitLab, a unified DevOps platform competing in the fast-changing market for AI-assisted coding and secure software delivery. As companies look at... 
    Via The Motley Fool
    Topics Artificial Intelligence Regulatory Compliance
    News headline image
    Whetstone Dumps 79,000 monday.com Shares Worth $15.3 Million ↗
    This cloud-based software provider serves organizations worldwide with modular tools for work management and collaboration. 
    Via The Motley Fool
    Topics Artificial Intelligence
    News headline image
    OptimizeRx Sets Fourth Quarter and Full Year 2025 Financial Results Conference Call for March 5, 2026, at 4:30 p.m. ET
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    OptimizeRx and Experian Collaborate to Improve Privacy-Safe Identity Resolution in Healthcare Marketing
    Life science marketers will be able to better measure the exposed audiences for a more complete, accurate, and transparent view of campaign engagement and effectiveness 
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    OptimizeRx Continues Expansion of the Company’s Point-Of-Care Network
    Strategic Partnerships Add Exclusivity in Leading EHR, e-Prescription, and Technology Companies, Increasing NPI Reach by 37% 
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    Why One Fund Still Has a $14 Million Bet on This Resale Stock Up 130% This Past Year ↗
    One luxury resale stock is quietly delivering its strongest growth in years — despite insiders taking some profits. 
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    BrightView Shares Down 30%: What a Full Fund Exit Signals for Investors ↗
    One fund just walked away from BrightView — here’s what the numbers suggest long-term investors should really pay attention to. 
    Via The Motley Fool
    Topics Regulatory Compliance
    < Previous 1 2 3 4 5 6 7 8 9 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.